Diabetes and palpitations are risk factors of atrial fibrillation. The Tromso study

被引：0
|
作者：
Nyrnes, A. [1 ]
Arnesen, E. [1 ]
Njolstad, I. [1 ]
Mathiesen, E. B. [1 ]
Wilsgaard, T. [1 ]
Lochen, M. L. [1 ]
机构：
[1] Univ Tromso, Tromso, Norway
来源：
EUROPEAN HEART JOURNAL | 2009年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：961 / 961
页数：1
相关论文
共 50 条
  • [1] Palpitations are predictive of future atrial fibrillation. An 11-year follow-up of 22,815 men and women: the Tromso Study
    Nyrnes, Audhild
    Mathiesen, Ellisiv B.
    Njolstad, Inger
    Wilsgaard, Tom
    Lochen, Maja-Lisa
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2013, 20 (05) : 729 - 736
  • [2] Factor v leiden mutation and risk of stroke in atrial fibrillation. The anticoagulation and risk factors in atrial fibrillation (ATRIA) study
    Go, AS
    Reed, GL
    Hylek, EM
    Phillips, KA
    Chang, Y
    Henault, LE
    Selby, JV
    Singer, DE
    CIRCULATION, 2001, 104 (17) : 530 - 530
  • [3] Incidence and risk factors for ibrutinib associated atrial fibrillation.
    Emole, Josephine Ngozi
    Viganego, Federico
    Schabath, Matthew B.
    Shah, Bijal D.
    Chavez, Julio C.
    Walko, Christine Marie
    McLeod, Howard L.
    Pinilla-Ibarz, Javier
    Fradley, Michael G.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [4] Inflammatory Biomarkers as Risk Factors for Future Atrial Fibrillation. An Eleven-Year Follow-Up of 6315 Men and Women: The Tromso Study
    Nyrnes, Audhild
    Njolstad, Inger
    Mathiesen, Ellisiv B.
    Wilsgaard, Tom
    Hansen, John-Bjarne
    Skjelbakken, Tove
    Jorgensen, Lone
    Lochen, Maja-Lisa
    GENDER MEDICINE, 2012, 9 (06) : 536 - 547
  • [5] Improving risk stratification in atrial fibrillation: Renal dysfunction and risk of thromboembolism and death in nonvalvular atrial fibrillation. The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study.
    Go, AS
    Hylek, EM
    Udaltsova, N
    Chang, YC
    Jensvold, NG
    Henault, LE
    Singer, DE
    CIRCULATION, 2004, 109 (07) : E92 - E92
  • [6] Atrial fibrillation and future risk of venous thromboembolism: the Tromso study
    Enga, K. F.
    Rye-Holmboe, I.
    Hald, E. M.
    Lochen, M. -L.
    Mathiesen, E. B.
    Njolstad, I.
    Wilsgaard, T.
    Braekkan, S. K.
    Hansen, J. -B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 (01) : 10 - 16
  • [7] Venous Thromboembolism Increases the Risk of Atrial Fibrillation: The Tromso Study
    Hald, Erin M.
    Enga, Kristin F.
    Lochen, Maja-Lisa
    Mathiesen, Ellisiv B.
    Njolstad, Inger
    Wilsgaard, Tom
    Braekkan, Sigrid K.
    Hansen, John-Bjarne
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2014, 3 (01): : e000483
  • [8] Diabetes mellitus - risk factor for atrial fibrillation. Potential therapeutic implications
    Meinertz, T.
    Sydow, K.
    HERZ, 2014, 39 (03) : 320 - 324
  • [9] Palpitations and Atrial Fibrillation
    Wachter, R.
    Rybak, K.
    AKTUELLE KARDIOLOGIE, 2015, 4 (06) : 392 - 395
  • [10] Impact of venous thromboembolism on future risk of atrial fibrillation - the Tromso study
    Enga, K. F.
    Mathiesen, E. H.
    Lochen, M. L.
    Mathiesen, E. B.
    Njolstad, I
    Wilsgaard, T.
    Braekkan, S. K.
    Hansen, J. B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 994 - 995
12345